학술논문
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus
Document Type
Article
Author
Source
In: Pediatric Drugs . (Pediatric Drugs, July 2024, 26(4):411-427)
Subject
Language
English
ISSN
11792019
11745878
11745878